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Abstract
Ku70 and Ku80 form a heterodimer called Ku that forms a holoenzyme with DNA dependent-protein kinase catalytic subunit
(DNA-PKCS) to repair DNA double strand breaks (DSBs) through the nonhomologous end joining (NHEJ) pathway. As
expected mutating these genes in mice caused a similar DSB repair-defective phenotype. However, ku70-/- cells and ku80-/-
cells also appeared to have a defect in base excision repair (BER). BER corrects base lesions, apurinic/apyrimidinic (AP) sites
and single stand breaks (SSBs) utilizing a variety of proteins including glycosylases, AP endonuclease 1 (APE1) and DNA
Polymerase b (Pol b). In addition, deleting Ku70 was not equivalent to deleting Ku80 in cells and mice. Therefore, we
hypothesized that free Ku70 (not bound to Ku80) and/or free Ku80 (not bound to Ku70) possessed activity that influenced
BER. To further test this hypothesis we performed two general sets of experiments. The first set showed that deleting either
Ku70 or Ku80 caused an NHEJ-independent defect. We found ku80-/- mice had a shorter life span than dna-pkcs-/- mice
demonstrating a phenotype that was greater than deleting the holoenzyme. We also found Ku70-deletion induced a p53
response that reduced the level of small mutations in the brain suggesting defective BER. We further confirmed that Ku80-
deletion impaired BER via a mechanism that was not epistatic to Pol b. The second set of experiments showed that free
Ku70 and free Ku80 could influence BER. We observed that deletion of either Ku70 or Ku80, but not both, increased
sensitivity of cells to CRT0044876 (CRT), an agent that interferes with APE1. In addition, free Ku70 and free Ku80 bound to
AP sites and in the case of Ku70 inhibited APE1 activity. These observations support a novel role for free Ku70 and free Ku80
in altering BER.
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Introduction
BER corrects a broad spectrum of DNA lesions [1] caused by
reactive oxygen species (ROS) and alkylating agents [2] that would
otherwise result in point mutations [3]. The damaged nucleotide is
first recognized by one of many DNA damage specific glycosylases
[4]. For example 8-oxoguanosine-glycosylase 1 (OGG1) is the
primary glycosylase to excise the major ROS-induced base lesion,
8-oxoG. Glycosylases remove the damaged base to generate an
apurinic/apyrimidinic (AP) site. AP endonuclease 1 (APE1) then
makes a nick 59 to the AP site, generating a dRP (deoxyribose
phosphate) intermediate and a one base gap. DNA Polymerase b
(Pol b) then fills in the missing nucleotide while its lyase activity
generates a 59 phosphorylated DNA strand by excising the 59
terminal dRP residue so that DNA ligase can repair the nick. BER
also repairs DNA single strand breaks (SSBs) that form sponta-
neously at AP sites, as a DNA repair intermediate or after
exposure to ROS. XRCC1 is critical for repairing SSBs by
interacting with a number of BER proteins including APE1 [5],
[6–8], and PARP-1[6,9]. Thus, deletion of BER components
disables the repair of base lesions, AP sites and SSBs[10].
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By contrast NHEJ repairs DNA DSBs. To initiate NHEJ, Ku70
and Ku80 form a heterodimer called Ku that forms a holoenzyme
with DNA-PKCS [11]. Cells deleted for any of these proteins
exhibited telomere end fusion [12], hypersensitivity to clastogenic
agents, and premature replicative senescence [13]. Mice deleted
for these proteins exhibited premature aging [14–18]. Thus,
deletion of Ku70, Ku80 or DNA-PKCS resulted in a similar
phenotype demonstrating a common defect in the holoenzyme. In
addition, XRCC4 and DNA ligase IV form a heterodimer to join
the broken ends. Cells deleted for either of these proteins also
exhibited hypersensitivity to clastogens, premature replicative
senescence [19] and early aging [20]. Thus, deletion of NHEJ
proteins caused a similar phenotype.
However, our data also show that cells deleted for either Ku70
or Ku80 exhibited an NHEJ-independent phenotype. We found
cells deleted for Ku70 or Ku80 were hypersensitive to ROS and
alkylating agents implicating defective BER [21,22]. However,
cells deleted for Lig4 did not exhibit these hypersensitivities
exonerating defective NHEJ. In addition, extracts from cells
deleted for Ku80, but not Lig4, exhibited reduced BER capacity
(correction of a U/G mismatch). Furthermore, ectopic expression
of OGG1 or PARP-1 in Ku80-deleted cells rescued hypersensi-
tivity to ROS [22] suggesting Ku80 deletion disabled BER. These
data suggested Ku80-deletion caused a BER defect that was
unrelated to NHEJ.
We hypothesized that free Ku70 (not bound to Ku80) and free
Ku80 (not bound to Ku70) could influence BER. Cells deleted for
either Ku70 or Ku80 did not exhibit the same sensitivity to ROS
agents [21] and extracts from cells deleted for Ku80, but not
Ku70, exhibited reduced BER capacity (correction of a U/G
mismatch) [22]. We further hypothesized that free Ku70 could
have activity in ku80-/- cells and free Ku80 could have activity in
ku70-/- cells [21,22]. This is possible since some Ku80 remains in
the absence of Ku70 [23] and vice versa [24]. To support this
hypothesis, we found deleting Ku70 resulted in a milder
phenotype than deleting Ku80 in p53-mutant mice and this
milder phenotype depended on Ku80 [21]. Thus, after deleting
Ku70 in p53-mutant mice, there were two events that contributed
to the phenotype: first, the loss of Ku70 and second, the activity of
free Ku80. It is also possible that free Ku70 could contribute to the
Ku80-mutant phenotype.
Here we test our model that proposes free Ku70 and/or free
Ku80 alter BER. First, we provide more data that show deletion of
either Ku70 or Ku80 caused a phenotype that was not due to
defective NHEJ. We found that ku80-/- mice had a shorter life span
than dna-pkcs-/- mice suggesting a phenotype greater than simply
deleting NHEJ. Next we show that ku70-/- mice exhibited an
elevated level of point mutations in the brain but only in the absence
of p53 suggesting a defect in BER.We also show that Ku80-deletion
in cells inhibited BER through a novel mechanism that is not
epistatic to Pol b. Second, we present data that show free Ku70 and
free Ku80 influence BER. Deletion of either Ku70 or Ku80, but not
both, disabled the repair of AP sites. Interestingly, free Ku70 and
free Ku80, but not the Ku heterodimer, associated with AP sites and
free Ku70 inhibited APE1 activity in vitro. Thus, Ku70 and Ku80
appear to have activity outside NHEJ and the Ku heterodimer that
influences BER.
Results
Ku80-deleted mice have a shorter life span than
DNA-PKCS-deleted mice
Deletion of either Ku70 of Ku80 caused any early aging
phenotype implicating a defect in NHEJ [16]. Yet in a p53-mutant
background the ku70-/- mice lived significantly longer than the
ku80-/- mice due to a lower incidence of pro-B cell lymphoma [21].
The presence of Ku80 was essential for this milder phenotype.
Thus, we proposed that Ku80 functioned outside of the Ku
heterodimer. To investigate the possibility that Ku80 functioned
outside of the DNA-PK holoenzyme, we measured the life spans
for mice deleted for either Ku80 or DNA-PKCS [11]. To guard
against phenotypic variation due to differences in genetic
background and environment, C57Bl6/J males were crossed to
FVB females (both are Ku80+/- DNA-PKCS
+/-) such that all mice
were C57Bl6/J*FVB F1 hybrid brothers and sisters raised in the
same cages. The ku80-/- mice exhibited a shorter life span than the
dna-pkcs
-/- mice for both males (Fig. 1A, p= 0.01) and females
(Fig. 1B, p,0.0001). Thus, deleting Ku80 is more severe than
deleting DNA-PKCS. Even though the mechanism for these
different life spans is not known, this observation demonstrates
that Ku80 has a function greater than the DNA-PK holoenzyme.
Ku70-mutant mice exhibited an elevated level of point
mutations in the absence of p53
Previously we analyzed ku80-/- mice for the level of chromosomal
rearrangements and point mutations in the liver and brain. We
found Ku80-deletion increased levels of chromosomal rearrange-
ments in a variety of tissues including the liver, as expected for
defective NHEJ [25]. However, there was no significant increase in
rearrangements in the brain, instead there was a decrease in point
mutations. We surmised that p53-mediated DNA damage responses
limited the number of recovered mutations. Here we tested if p53-
dependent DNA damage responses influenced the level of
mutations in ku70-/- livers (Fig. 1C) and brains (Fig. 1D) with and
without p53 using a forward mutation detection system based on
lacZ. We crossed the Ku70 mutation [26] and the p53mutation [27]
into mice that carry the pUR288-lacZ reporter [28]. These mice
were sacrificed at 4 months and analyzed for the levels of
rearrangements (size change) and point mutations (no size change)
in their livers and brains.
First we looked at the level of chromosomal rearrangements.
Similar to the results with ku80-/- mice [25], Ku70-deletion
increased chromosomal rearrangements in liver, but not brain. In
addition, we found that p53-deletion further increased the levels of
chromosomal rearrangements in the liver, but not brain. However,
this was not statistically significant because of one outlier among
the replicate determinations in the double knockouts (refer to
Fig. 2C, D for p values). Overall, however, it is possible to
conclude that the liver is more prone to carry chromosomal
rearrangements than the brain.
Next we looked at point mutations. Similar to ku80-/- brains
[29], we found decreased levels of small mutations in ku70-/-
p53+/+ brains compared to Ku70+/+ p53+/+ brains. The levels of
small mutations were also lower as compared to Ku70+/+ p53-/-
brains, but this was not significant. Yet, ku70-/- p53-/- brains
exhibited increased point mutations as compared to ku70-/- p53+/+
and Ku70+/+ p53-/- brains. Thus, p53 reduced the level of small
mutations in the ku70-/- brain. This observation supports the
hypothesis that deletion of either Ku70 or Ku80 increased base
lesions that are then limited through p53-mediated responses and
corroborate our previous observations with tissue culture cells that
either Ku70 and/or Ku80 influence the repair of base lesions [22].
The increased sensitivity to an alkylating agent in cells
compromised for Ku80 and Pol b was additive
The above experiments support the possibility that deleting
either Ku70 or Ku80 altered BER in mice. Therefore, we
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performed an epistatic analysis for Ku80 and Pol b to determine if
they repaired methyl methanesulfonate (MMS)-induced lesions via
the same sub-pathway [2]. We analyzed mouse embryonic
fibroblasts deleted for p53 since NHEJ-deletion caused p53-
mediated replicative senescence that prevents their proliferation;
therefore, all cells were deleted for p53, including control cells
[13,21]. Pol b was depleted in p53-/- control and ku80-/- p53-/-
MEFs by RNA interference using a mouse Pol b -specific shRNA-
expressing lentivirus similar to one we previously reported [30].
We used this lentivirus to transduce p53-/- control and ku80-/-
p53-/- MEF to generate corresponding cells with a deficiency in
the expression of Pol b (Fig. 2A). Each group of cells was also
transduced with a control, GFP-expressing lentivirus. These cells
were then used to perform a dose-response analysis to MMS. We
found Pol b depletion increased the sensitivity to MMS for control
and ku80-/- p53-/- cells; yet the latter appear more sensitive than
the former genotype (Fig. 2B). Thus, Pol b -mediated repair of
MMS-induced lesions in both control and ku80-/- p53-/- MEFs.
We also found Pol b over-expression (Fig. 2C) rescued sensitivity to
MMS for ku80-/- p53-/- cells (Fig. 2D). Thus, these data suggest
that Pol b and Ku80 are not epistatic and that Ku80 deletion
negatively impacts the gap tailoring or DNA synthesis/ligation
stages of BER without disabling Pol b [2].
Free Ku70 and free Ku80 sensitize cells to an APE1
inhibitor
Our previously published results in mice [21] and tissue culture
cells [22] suggest that either Ku70 or Ku80 function outside of the
Ku heterodimer to influence BER. We also found that Ku80-
deletion decreased the capacity to repair AP sites [22]. Therefore,
we tested APE1 capacity in mouse fibroblasts deleted for Ku70 or
Ku80 or both to provide a complementary biological analysis. We
found that ku80-/- p53-/- mouse embryonic fibroblasts [13] were
hypersensitive to CRT0044876 (CRT), an agent that specifically
inhibits APE1 nicking [31] (Fig. 3A). Expression of mouse Ku80,
but not vector alone, rescued hypersensitivity. Ectopic APE1
overexpression also rescued CRT hypersensitivity, supporting the
possibility that free Ku70 competitively inhibited APE1 nicking.
We then compared ku70-/- p53-/- and ku80-/- p53-/- dermal
fibroblasts [21] to ku70-/- ku80-/- p53-/- dermal fibroblasts to
determine if free Ku70 caused CRT hypersensitivity in ku80-/-
p53-/- cells and if free Ku80 caused CRT hypersensitivity in
ku70-/- p53-/- cells. We found ku70-/- p53-/- cells and ku80-/- p53-/-
cells, but not ku70-/- ku80-/- p53-/- cells, were hypersensitive to
CRT (Fig. 3B). Therefore, free Ku70 and free Ku80 were needed
for CRT hypersensitivity. By comparison, all three genotypes were
similarly hypersensitive to c-radiation (Fig. 3C) showing the Ku
heterodimer was needed to repair the c-radiation-induced DSBs.
Thus, free Ku70 and free Ku80 affected BER, but not NHEJ.
Figure 1. In vivo analysis. Life span for ku80-/- and dna-pkcs
-/- (A) males and (B) females (45 mice in each cohort). Mutation spectrum in
ku70-/- mice with and without p53 in the (C) liver and (D) brain. Size changes are chromosomal rearrangements that include translocations and large
insertions/deletions. No size changes are point mutations (base changes and small insertions/deletions). A student t test was performed for a
statistical analysis and tables are presented showing all possible comparisons.
doi:10.1371/journal.pone.0086358.g001
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The individual Ku70 and Ku80 subunits, but not the Ku
heterodimer, preferentially bound to a substrate with an
AP site
Previously Ku80 was shown to crosslink with AP sites in HeLa
cell extracts and the Ku heterodimer along with DNA-PKCS was
shown to inhibit AP site cleavage by APE1 [32]. For efficient end
joining Ku was also shown to process AP sites at DNA ends with
Ku70’s 59-dRP/AP lyase activity [33]. Here we analyzed the
potential mechanism for the increased CRT sensitivity observed in
cells deleted for Ku70 or Ku80, but not both. We hypothesized
that free Ku70 and free Ku80 bound to AP sites to interfere with
their repair. This is possible since some Ku80 remains in the
absence of Ku70 [23] and vice versa [24]. For this purpose we
used an oligonucleotide with an internal U/G mismatch and then
converted the uracil to an AP site with uracil DNA glycosylase
(UDG). Binding assays were performed with this AP/G substrate
and the parental U/G substrate or the same substrate with a C
instead of a U (C/G substrate). Biotinylated substrates were
exposed to myc-tagged Ku70 (myc-Ku70) or myc-tagged Ku80
Figure 2. Epistatic analysis for Ku80 and Pol b. All cells are deleted
for p53 (even controls) to avoid early replicative senescence. Shown is
the average of three experiments. (A) Western showing RNAi
knockdown of Pol b in p53-/- control and ku80-/- p53-/- fibroblasts that
stably express a shRNA plasmid specific for mouse Pol b (three clones).
PCNA was loaded to normalize for nuclear protein levels. The
expression of endogenous Pol b in the shRNA-transduced cell lines
was undetectable by immunoblot, consistent with our earlier reports
for this mouse Pol b -specific shRNA [30]. (B) Dose-response to MMS for
p53-/- control and ku80-/- p53-/- fibroblasts with and without mouse Pol b
shRNA expression. (C) Western showing increased Pol b levels for the
ku80-/- p53-/- fibroblasts that stably express a Pol b expression plasmid
(two clones). Beta-actin was loaded to normalize for cellular protein
levels. (D) Pol b -overexpression rescues Ku80-mutant phenotype for
MMS.
doi:10.1371/journal.pone.0086358.g002
Figure 3. CRT0044876 (CRT) survival fraction (SF). All cells are
deleted for p53 (even controls) to avoid early replicative senescence.
Shown is the average of three experiments. (A) Cells deleted for Ku80
are hypersensitive to CRT. Expression of APE1 or mouse Ku80 rescued
CRT hypersensitivity for Ku80-mutant cells. (B) Cells deleted for either
Ku70 or Ku80 but not both were hypersensitive to CRT demonstrating
independent function for the individual Ku subunits as opposed to the
Ku heterodimer. (C) Cells deleted for Ku70 or Ku80 or both were
hypersensitive to c-radiation demonstrating the Ku heterodimer
repaired damage as opposed to independent function for the individual
proteins.
doi:10.1371/journal.pone.0086358.g003
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(myc-Ku80) after in vitro translation, diluted on ice with NaBH4 to
trap proteins that form a Schiff base with the deoxyribose of the
AP site [33,34] and isolated with streptavidin-coated magnetic
beads. Western blotting was performed with an anti-myc antibody.
Myc-Ku70 exhibited preferential binding to the AP/G substrate as
compared to the C/G (Fig. 4A, compare lanes 2 & 3,
p = 0.000112, student t test) and U/G (Fig. 4A, compare lanes 2
& 4, p = 0.005) substrates. Myc-Ku80 also exhibited preferential
binding to the AP/G substrate as compared to the C/G (Fig. 4A,
compare lanes 2 & 3, p = 0.0022) and U/G (Fig. 4A, compare
lanes 2 & 4, p= 0.0015) substrates. Thus, free Ku70 and free Ku80
bound to AP sites.
The Ku heterodimer binds to DNA ends [35]; therefore, we
tested if Ku would preferentially bind to an oligonucleotide
substrate with an AP site by combining full length myc-Ku70 and
myc-Ku80. However, unlike myc-Ku70 and myc-Ku80 alone, the
combination did not preferentially bind to the AP/C substrate as
compared to the C/G (Fig. 4A, compare lanes 2 & 3, p= 0.436)
and U/G (Fig. 4A, compare lanes 2 & 4, p= 0.344) substrates.
Instead, the Ku heterodimer bound to all substrates, implicating
end binding. Thus, the Ku heterodimer did not preferentially bind
to an AP site. This observation also suggests that free Ku70 and
free Ku80 do not efficiently bind to DNA ends as compared to AP
sites. Therefore, free Ku70 and free Ku80, but not the Ku
heterodimer, bound to AP sites.
N-terminal Ku70, but not C-terminal Ku70, preferentially
bound to a substrate with an AP site
Mechanistically, it is not clear how free Ku70 and free Ku80
could inhibit AP site repair in wild type cells or animals. One
possibility is that one subunit is degraded while leaving the other
intact. Granzyme A (GzmA) cleaves Ku70 at Arg301 to separate
the two Ku80 binding domains (Fig. 4B) thereby preventing
formation of the Ku heterodimer [36] as a part of the caspase-
independent cell death pathway in killer cell cytotoxic granules
[37]. Interestingly, GzmA also cleaves APE1 to induce cell death;
thus, Ku70 cleavage could further diminish BER.
Since GzmA cleaves Ku70 at Arg301, we tested myc-Ku701–300
for its binding preference to these substrates. Similar to full length
Ku70 (1–609), Myc-Ku701–300 exhibited preferential binding to
the AP/G substrate as compared to the C/G (p= 0.0179) and
U/G (p= 0.0131) substrates (Fig. 4B, lanes 2–4). In addition, a
competition assay with myc-Ku701–300 was performed with hot
(biotinylated) and cold (not biotinylated) substrate. We found 30X
cold AP/G competed out hot AP/G when compared to no
competitor (Fig. 4B compare lanes 2 & 5, p= 0.00037). However,
Figure 4. Ku70 and Ku80 bind to AP sites. We show 10% input for in vitro translated product. The same concentration of biotinylated substrate
were used for each reaction of the binding assays. Right panel shows the relative band intensity as measured with the Kodak document program and
as compared to 10% input. Shown is the average of three experiments with error bars (standard deviation). Statistics are shown in the results. (A)
Ku70 and Ku80, but not Ku70+Ku80, preferentially bind to the AP site. (B) GzmA cleaves Ku70 at Arg(301). Cleavage at this site separates the two Ku80
binding domains. The GzmA N-terminal Ku70 cleavage product (Ku701–300) binding and competition assays. (C) Ku701–115, but not Ku70115-609, bound
to the AP/G substrate at a higher level than the C/G and U/G substrates.
doi:10.1371/journal.pone.0086358.g004
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100X cold C/G (Fig. 4B compare lanes 2 & 6, p = 0.054) and
100X cold U/G (Fig. 4B compare lanes 2 & 7, p= 0.062) did not
compete with the AP substrate to the same extent as 30X cold
AP/G. Thus, Ku701–300 (the N-terminal GzmA cleavage product)
preferentially bound to AP sites. We also found that preferential
binding to the AP/G substrate was seen for myc-Ku701–115 as
compared to the C/G (p= 0.031) and U/G (p= 0.036) substrates
(Fig. 4C). However, myc-Ku70115–609 did not display preferential
binding to the AP/G as compared to the C/G (p= 0.226) and
U/G (p= 0.166) substrates (Fig. 4C). Thus, myc-Ku701–115 was
necessary and sufficient to preferentially bind to the AP/G
substrate, suggesting the N-terminal Ku70 cleavage product
associates with AP sites to inhibit APE1.
Full length and N-terminal Ku70, but not C-terminal Ku70
or Ku80, inhibited APE1 activity
Free Ku70 and free Ku80 binding to AP sites suggest a possible
mechanism for interfering with APE1 activity. This activity was
tested using a real-time molecular beacon assay [38] that measures
fluorescence emitted after purified APE1 nicks 59 to the AP site to
release a FAM fluorophore from the dabsyl quench located on the
complementary DNA strand. APE1 effectively released the FAM
fluorophore from the DNA substrate without Ku70 (Fig. 5A,
p,0.0001, student t test). Addition of myc-Ku701–609 (full length)
prohibited APE1 nicking (Fig. 5A, p,0.0001). However, addition
of myc-Ku70115–609 did not affect APE1 nicking (Fig. 5B,
p = 0.7164). Furthermore, addition of myc-Ku701–115 (Fig. 5C,
p,0.0001) myc-Ku701–300 (Fig. 5D, p,0.0001) impaired APE1 as
compared to no myc-Ku70, though not as efficiently as full-length
myc-Ku70. These data indicate that myc-Ku701–115, myc-
Ku701–300 and myc-Ku701–609, but not myc-Ku70115–609, inhib-
ited APE1 activity in keeping with the AP binding data. Thus,
Ku70 binding to AP sites inhibits APE1 nicking. Interestingly,
Ku80 did not inhibit APE1 activity by this assay (not shown),
though a previous report showed that Ku and DNA-PKCS
inhibited AP site cleavage by APE1 [32].
Disscussion
Mice and cells deleted for either Ku70 or Ku80 exhibit a
complex phenotype that is not solely due to disruption of NHEJ; it
is possible some of this complexity is due to altered BER. In mice
Ku80-deletion had a more severe impact on life span than DNA-
PKCS-deletion suggesting Ku80 does more than NHEJ. The level
of small mutations also changed in mouse brains deleted for either
Ku70 or Ku80 [25] implicating a change in BER. To further
implicate altered BER, cells deleted for either Ku70 or Ku80, but
not Lig4, exhibited increased sensitivity to ROS and alkylating
agents and cells deleted for Ku80, but not Lig4, were deficient in
repairing AP sites and cell extracts were deficient in correcting a
U/G mismatch in an oligonucleotide substrate [21,22]. Further-
more, ectopic expression of either OGG1 or PARP-1 recused
hypersensitivity of ku80-/- cells to ROS while ectopic expression of
Pol b or APE1 rescued hypersensitivity to an alkylating agent and
an APE1 inhibitor, respectively. These rescue experiments suggest
that deleting either Ku70 or Ku80 decreased BER capacity but
still left the BER pathway intact.
Previously published data support the possibility that Ku70 and
Ku80 have activity outside the heterodimer. For example, Ku70
and Ku80 passed through the nucleus using different nuclear
localization signals [39,40] and c-radiation increased levels of
Ku70 but not Ku80 [41]. Ku70 also associated with DNA [42]
and with a variety of proteins independent of Ku80. These
protein-protein interactions could influence cell death [43,44],
chromatin metabolism[45–47] and DNA repair [48]. Thus, Ku70
and Ku80 might function outside the Ku heterodimer to influence
a variety of biological outcomes.
Our data also suggest that free Ku70 and free Ku80 could
influence the phenotype of cells and mice deleted for their partner
in the Ku heterodimer. In a p53-mutant background, we found
free Ku80 ameliorated the severity of Ku70-deletion in mice [21].
We also show that deletion of either Ku70 or Ku80, but not both,
increased sensitivity to an APE1 inhibitor. Based on these
biological observations we observed extracts from cells deleted
for Ku80, but not Ku70 or Lig4, were deficient in repairing an
oligonucleotide with a U/G mismatch [22]. Now we show that
both free Ku70 and free Ku80, but not the Ku heterodimer,
preferentially bound to an oligonucleotide with an AP site and that
free Ku70 inhibited APE1 activity. Thus, Ku70 and Ku80 have
activity independent of the Ku heterodimer that can influence the
phenotype of cells and mice deleted for their partner.
The impact free Ku70 and free Ku80 could have on BER might
be physiologically relevant to GzmA-mediated cell death. GzmA is
a serine protease that rapidly migrates from the cytosol to the
mitochondria to cripple electron transport and increase ROS [2].
To further enhance cell death, GzmA cleaves APE1 to disable
BER, the pathway mostly responsible for correcting ROS-induced
lesions [37]. GzmA also cleaves Ku70 in cytotoxic T lymphocytes
and natural killer cells [36] to generate an N-terminal Ku701–300
that binds to AP sites and impair APE1 activity. Our data suggests
that Ku70 cleavage will further diminish BER to enhance cell
death.
From a larger perspective our data suggests that nonequimolar
ratios of Ku70 and Ku80 could impair BER in a wide range of
cells, even those that do not express GzmA (or in cells that
inappropriately express GzmA). For example, Ku70, but not
Ku80, levels decline in lymphocytes [49]. This could lead to
inadequate BER that would ultimately result in elevated DNA
damage responses or, in the absence of these responses, to elevated
point mutations. Thus, non-equimolar ratios of Ku70 and Ku80
could diminish BER and enhance p53-mediated cell clearance.
This could contribute to generalized aging since Ku70 and Ku80
levels vary with age [50].
Materials and Methods
Ethics statement
All animal work was approved by the ethics committee of the
National Institutes for Public Health and the Environment
(RIVM), Antonie van Leeuwenhoeklaan, Bilthoven, The Nether-
lands, IACUC protocol #:99047x.
Life span analysis
F1 hybrid animals were generated with a C57Bl6/J*FVB
background. Ku80+/- [51] and DNA-PKCS
-/- mice [52] were re-
derived and back crossed to C57Bl6/JIco (Charles River, France)
and FVB/NHanTMHsd (Harlan, Germany) using a speed
congenics approach [53]. ku80-/- and dna-pkcs
-/- cohorts were
generated using double heterozygous knock out breeders (Ku80+/-
DNA-PKCS
-/-). All male breeders were on C57Bl6/J-pUR288 and
all female breeders on FVB background. Thus, the ku80-/- and
dna-pkcs
-/- cohorts are F1 brothers and sisters raised in the same
cages to eliminate phenotypic variances due to genetic background
and environment. They were kept on a 12-hour light/12-hour
dark cycle at a standard temperature of 20uC. CRM pelleted
maintenance diet (Special Diet Services, UK) and water supplied
ad libitum. Survival (life span) was analyzed so there was no
intervention. For the end of life analysis, moribund mice were
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sacrificed by exsanguination after sedation with an intramuscular
injection of a Ketamine-Rompun mixture. The Criteria for
euthanizing a moribund mouse was .15% weight loss within 2
weeks, not responsive to touch, prominent appearance of ribs,
spine and hips, hunch body position, matted fur, prolapse of the
rectum or uterus, or a visible tumor.
This study was carried out in strict accordance with institutional
guidelines and regulations. All animal work was approved by the
ethics committee of the National Institutes for Public Health and
the Environment (RIVM), Antonie van Leeuwenhoeklaan,
Bilthoven, The Netherlands, IACUC protocol #:99047x. These
were survival studies; therefore, mice were monitored every day
without intervention. Moribund mice were sacrificed with
ketamine/xylazine anesthesia followed by cervical dislocation
and all efforts were made to minimize suffering and discomfort.
Criteria for moribund were .15% weight loss within 2 weeks, not
responsive to touch, prominent appearance of ribs, spine and hips,
hunch body position, matted fur, or a visible tumor.
Mutation analysis
The mutation spectrum was performed by crossing mice with a
mutation in Ku70 [26] and p53 [27] into mice with the pUR288-
lacZ reporter (line 60, integration sites on chromosomes 3 and 4)
[28,54]. The pUR288-lacZ reporter was bred to homozygosity.
The animals were maintained in the UTHSCSA’s animal facility.
They were kept on a 12-hour light/12-hour dark cycle at a
standard temperature of 23uC. Standard lab chow (Harlan
Teklad, Madison WI) and water were supplied ad libitum. Mice
were sacrificed by CO2 inhalation followed by cervical dislocation
at 4 months of age. DNA preparation, plasmid rescue and
mutation analysis was performed as described [25,55].
CRT0044876 survival fraction
Dose response assays were performed as previously described
for HeLa cells [56].
In vitro translation
For In vitro translation we followed the TNTH Quick Coupled
Transcription/Translation System (Promega, WI) in 50 ml. For
full length Ku70, Ku70 deletions and Ku80 PCR products were
cloned into the pCS2/myc expression vector (Invitrogen, Carls-
bad, CA) using Xho1 or EcoR1 and Asc1 sites (underlined) that
adds an NH2-terminal c-Myc tag.
Ku70 1–609:
Ku70-XhoI-Top (59-ACCGCTCGAGTCAGGGTGGAGT-
CATATTACAAA-39)
Ku70-AscI-Bottom (59-AAGGCGCGCCTCAGTCCTG-
GAAGTGCTTGGTGA-39)
Ku70 1–115:
Ku70-XhoI-Top: 59-ACCGCTCGAGTCAGGGTGGAGT-
CATATTACAAA-39
Ku70N 1-115 Asc1-Bottom: 59-
AAGGCGCGCCTCGTTTTGCACCTGG-39
Ku70 1–300:
Ku70-XhoI-Top: 59-ACCGCTCGAGTCAGGGTGGAGT-
CATATTACAAA-39
Ku70N 1–300 Asc1-Bottom: 59-AAGGCGCGCCCTG-
TACTTGTATTAAAGGTCC-39
Ku70-115-609:
Ku70-115-609 Xho1-Top: 59-AACTCGAGCTCGAC-
CAGTTTAAGGGACAAC-39
Ku70-AscI-Bottom: 59-AAGGCGCGCCTCAGTCCTG-
GAAGTGCTTGGTGA-39
Ku80:
Ku80-EcoRI-Top (59-TTGAATTCAGTGCGGTCGGG-
GAATAAGGCAG-39)
Ku80-AscI-Bottom (59-AAGGCGCGCCCTATATCATGTC-
CAATAAATCGTCCA-39).
In vitro binding assay
To make the double strand substrate, single strand oligonucle-
otides were mixed in equimolar amounts (250 nM) as measured by
Figure 5. Molecular beacon assay to measure APE1 activity. No Ku70 was compared to Ku70 added to substrate with or without APE1.
Fluorescence: the excitation wavelength is 485 nm and the emission wavelength is 538 nm. Shown is the average of three experiments with error
bars (standard deviation). (A) Ku701–609 (full-length Ku70) (B) Ku70115–609. (C) Ku701–115. (D) Ku701–300.
doi:10.1371/journal.pone.0086358.g005
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UV spectrometry, incubated at 90uC (5 min) and slowly cooled to
24uC. The AP site was generated in the U/G substrate after
treatment with E. coli UDG (5 U/pmol DNA, 50 mM Tris-HCl
pH 8.0, 50 mM NaCl, 50 mM KCl, and 5 mM MgCl2). The
substrate was biotinylated.
Sequences:
U strand: 59-biotin-GCCCTGCAGGTCGAUTCTAGAG-
GATCCCCGGGTAC-39
C strand: 59-biotin-GCCCTGCAGGTCGACTCTAGAG-
GATCCCCGGGTAC-39
Template strand: 59-GTACCCGGGGATCCTCTAGA
GTCGACCTGCAGGGC-39.
For NaBH4 trapping [34] we used 10 ml reaction mixtures
(50 mM Tris-HCl pH 8.0, 50 mM NaCl, 15 mM EDTA, 250 nM
biotinylated-AP/G substrate) and in vitro translation (40 mg)
prepared on ice and incubated at 37uC (15 min). Then reaction
mixtures were diluted on ice with NaBH4 (final concentration
20 mM) and incubated at 0uC (30 min). 10 mg of streptavidin-
coated magnetic beads (Dynabeads M280, Dynal) was added to
the mixture on a rotator at 4uC (15 min). Beads (diameter
,2.8 mm, 300pmol biotin-binding sites/mg and washed twice in
50 mM Tris-HCl pH 7.4 and 0.1% BSA to remove NaN3) were
applied as a suspension (6-76108 beads/ml, 2 mg of beads in
20 ml) in phosphate-buffered saline (PBS, 0.1% BSA and 0.02%
NaN3). After incubation with mixture, beads were washed three
times (1 ml PBS), resuspended in 20 ml of 1X SDS (50 mM Tris-
HCl pH 6.8, 2% SDS, 10% glycerol, 1% b-mercaptoethanol,
12.5 mM EDTA and 0.02% bromophenol blue) and heated
(5 min). Soluble fraction was separated by 10% SDS PAGE.
Proteins were immunoblotted with mouse anti-human c-Myc
antibody (BD Biosciences, MD) according to manufacturer’s
instructions.
Competition assay
AP/G competitor has same sequences to AP/G substrate but
without 59 end biotin labeling. The AP site was generated in U/G
competitor after treatment with E. coli uracil DNA glycosylase
(5 U/pmol DNA, 50 mM Tris-HCl pH 8.0, 50 mM NaCl,
50 mM KCl, and 5 mM MgCl2). C/G competitor has same
sequences to C/G substrate without 59 end biotin labeling. U/G
competitor has same sequences to U/G substrate without 59 end
biotin labeling. For competition assay, each tube contained AP/G
substrate (50 nM) with AP/G competitor (1.5 mM), C/G compet-
itor (5 mM) and U/G competitor (5 mM) and did same process the
incubation with in vitro translation samples, after that pulled down
with streptoavidin beads and trapped by treating NaBH4. After
washing, the beads were resuspended in 20 ml of 1X SDS sample
buffer and heated for 5 min and soluble fraction were separated by
10% SDS PAGE. Proteins were immunoblotted with mouse anti-
human c-Myc antibody (BD Biosciences, MD) according to
manufacturer’s instructions.
Molecular beacon assay for APE1 activity
APE1 activity was measured using a modification of our
recently described BER molecular assay [57–59]. All oligonucle-
otides were purchased from Sigma-Aldrich (Saint Louis, MO):
Top-FAM-59-GAGAAWATAGTCGCC-39 Bottom-DAB-39-
CTCTTGTATCAGCGC-59 [W; Tetrahydrofuran (THF)]. Oli-
gonucleotides were mixed in equimolar amount (250 nM), heated
at 90uC for 5 min, and then slowly cooled down to room
temperature to form a double stranded DNA substrate. An
oligonucleotide containing a THF AP site mimic was used in the
APE1 molecular beacon substrate. The top strand was labeled on
the 59 end with a FAM fluorophore, the bottom on the 39end with
a dabsyl (DAB) quench. Upon APE1 cleavage, the fluorophore
dissociated from the dabsyl quench, causing an increase in
fluorescence, essentially as described [57–59]. All APE1 (New
England Biolabs, Ipswich, MA) cleavage reactions were carried
out in a buffer containing 20 mM Tris-acetate, pH 7.9, 10 mM
Magnesium acetate, 50 mM Potassium acetate, 1 mM dithiothre-
itol. All reactions were performed at 37uC. Excitation and
emission wavelengths for time curves were 485 and 538 mM,
respectively. Standard reaction mixtures (100 ml) for the molecular
beacon assay contained 20 mM Tris-acetate, pH 7.9, 10 mM
Magnesium acetate, 50 mM Potassium acetate, 1 mM dithiothre-
itol, 250 nM AP DNA duplex and in vitro translation samples
(40 mg) and APE1 (10 u) were prepared on ice and then measured
at 37uC, every 10 sec. for 10 min.
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